-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VrTabUFVbiWqW9CGwNu+0eEPqf5z7ow0hAFmjeP7tPZOIL3N7bLF+SpX20iKPVEG HqnqkBu50/e4R6ofylvHEg== 0001144204-11-008575.txt : 20110214 0001144204-11-008575.hdr.sgml : 20110214 20110214192105 ACCESSION NUMBER: 0001144204-11-008575 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101231 FILED AS OF DATE: 20110214 DATE AS OF CHANGE: 20110214 EFFECTIVENESS DATE: 20110214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC CENTRAL INDEX KEY: 0001346824 IRS NUMBER: 830406777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12884 FILM NUMBER: 11611016 BUSINESS ADDRESS: STREET 1: 20 PARK PLAZA, SUITE 905 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2500 MAIL ADDRESS: STREET 1: 20 PARK PLAZA, SUITE 905 CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 v211259_13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2010 Check here if Amendment [_]; Amendment Number: ___________ This Amendment (Check only one): [_] is a restatement. [_] adds new entries. Institutional Investment Manager Filing this Report: Name: RA Capital Management, LLC ------------------------------------- Address: 20 Park Plaza, Suite 905 ------------------------------------- Boston, MA 02116 ------------------------------------- Form 13F File Number: 28-12884 -------- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Peter Kolchinsky ------------------------------------- Title: Manager ------------------------------------- Phone: (617) 778-2500 ------------------------------------- Signature, Place, and Date of Signing /s/ Peter Kolchinsky Boston, MA February 14, 2011 - -------------------------- -------------------------- ---------------------- [Signature] [City, State] [Date] Report Type (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: NONE FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ----------------- Form 13F Information Tabel Entry Total: 19 ----------------- Form 13F Information Table Value Total: 123,340 ----------------- (thousands) List of Other Included Managers: NONE FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 - --------------------------- ------------ ----------- -------- ---------------------- ---------- -------- --------------------- TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE/ SHARED/NONE - ------------------------------------------------------------------------------------------------------------------------------------ ALEXION PHARMACEUTICALS INC COM 015351 10 9 8,140 101,050 SH SOLE N/A 101,050 ARTHROCARE CORP COM 043136 10 0 11,450 368,630 SH SOLE N/A 368,630 BIOGEN IDEC INC COM 09062X 10 3 7,109 106,030 SH SOLE N/A 106,030 BIOSPECIFICS TECHNOLOGIES CO COM 090931 10 6 7,680 300,000 SH SOLE N/A 300,000 COLUMBIA LABS INC COM 197779 10 1 2,316 1,020,343 SH SOLE N/A 1,020,343 CORCEPT THERAPEUTICS INC COM 218352 10 2 270 70,000 SH SOLE N/A 70,000 DYNAVAX TECHNOLOGIES CORP COM 268158 10 2 10,640 3,325,000 SH SOLE N/A 3,325,000 EXACT SCIENCES CORP COM 30063P 10 5 4,245 709,920 SH SOLE N/A 709,920 INHIBITEX INC COM 45719T 10 3 3,288 1,264,760 SH SOLE N/A 1,264,760 JAZZ PHARMACEUTICALS INC COM 472147 10 7 8,345 424,040 SH SOLE N/A 424,040 ONCOGENEX PHARMACEUTICALS IN COM 68230A 10 6 8,397 500,096 SH SOLE N/A 500,096 ONYX PHARMACEUTICALS INC COM 683399 10 9 7,450 202,050 SH SOLE N/A 202,050 PHARMASSET INC COM 71715N 10 6 8,070 185,261 SH SOLE N/A 185,261 SEQUENOM INC COM NEW 817337 40 5 10,478 1,304,850 SH SOLE N/A 1,304,850 TARGACEPT INC COM 87611R 30 6 10,564 398,638 SH SOLE N/A 398,638 UNITED THERAPEUTICS CORP DEL COM 91307C 10 2 6,515 103,050 SH SOLE N/A 103,050 VALEANT PHARMACEUTICALS INTL COM 91911K 10 2 5,983 211,500 SH SOLE N/A 211,500 VISION-SCIENCES INC DEL COM 927912 10 5 142 102,298 SH SOLE N/A 102,298 XENOPORT INC COM 98411C 10 0 2,258 265,000 SH SOLE N/A 265,000
-----END PRIVACY-ENHANCED MESSAGE-----